| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6147170 | American Journal of Obstetrics and Gynecology | 2010 | 8 Pages |
Abstract
IL6R is overexpressed in epithelial ovarian malignancies because of increases in a soluble IL6R variant, in the sheddases for full-length IL6R and host IL6R expression. Soluble IL6R may be an efficacious target for reducing IL6-mediated ovarian tumor progression.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Kellie S. MD, Holly M. BSc, Marcia C. MD, William E. MD, Angela F. PhD,